DAPK1 modulates a curcumin-induced G2/M arrest and apoptosis by regulating STAT3, NF-κB, and caspase-3 activation

Biochemical and Biophysical Research Communications

Volumn 434, Issue 1, 2013, Pages 75-80

  Wu, Bingshan ^a,b,c   Yao, Hui ^b,c   Wang, Shanshan ^b,c   Xu, Ruxiang ^a,b,c  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c Beijing Institute of Neurosurgery   (China)

Author keywords

Apoptosis; Cell cycle arrest; Curcumin; DAPK1; Signaling pathway

Indexed keywords

CASPASE 3; CURCUMIN; DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ATTENUATION; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CASPASE 3; CELL DIVISION; CELL LINE, TUMOR; CURCUMIN; G2 PHASE; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEUROBLASTOMA; NF-KAPPA B; STAT3 TRANSCRIPTION FACTOR;

CURCUMA LONGA;

EID: 84876792588     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.063     Document Type: Article

References (25)

1. Ravindran J., Prasad S., Aggarwal B.B. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?. AAPS J. 2009, 11:495-510.
2. Anand P., Sundaram C., Jhurani S., Kunnumakkara A.B., Aggarwal B.B. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett. 2008, 267:133-164.
3. Shehzad A., Lee Y.S. Molecular mechanisms of curcumin action: signal transduction. Biofactors 2013, 39:27-36.
4. Cohen O., Feinstein E., Kimchi A. DAP-kinase is a Ca2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J. 1997, 16:998-1008.
5. Yoo H.J., Byun H.J., Kim B.R., Lee K.H., Park S.Y., Rho S.B. DAPk1 inhibits NF-kappaB activation through TNF-alpha and INF-gamma-induced apoptosis. Cell Signal. 2012, 24:1471-1477.
6. Wang W.J., Kuo J.C., Yao C.C., Chen R.H. DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. J. Cell Biol. 2002, 159:169-179.
7. Yamamoto M., Hioki T., Ishii T., Nakajima-Iijima S., Uchino S. DAP kinase activity is critical for C(2)-ceramide-induced apoptosis in PC12 cells. Eur. J. Biochem. 2002, 269:139-147.
8. Jackson C., Ruzevick J., Amin A.G., Lim M. Potential role for STAT3 inhibitors in glioblastoma. Neurosurg. Clin. N Am. 2012, 23:379-389.
9. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431-436.
10. Freudlsperger C., Greten J., Schumacher U. Curcumin induces apoptosis in human neuroblastoma cells via inhibition of NFkappaB. Anticancer Res. 2008, 28:209-214.
11. Huang S., Sinicrope F.A. Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cells. Mol. Cancer Ther. 2010, 9:742-750.
12. Lin Y., Stevens C., Hupp T. Identification of a dominant negative functional domain on DAPK-1 that degrades DAPK-1 protein and stimulates TNFR-1-mediated apoptosis. J. Biol. Chem. 2007, 282:16792-16802.
13. Saydmohammed M., Joseph D., Syed V. Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells. J. Cell Biochem. 2010, 110:447-456.
14. Hupp T.R. Death-associated protein kinase (DAPK) and signal transduction. FEBS J. 2010, 277:47.
15. Fu S., Kurzrock R. Development of curcumin as an epigenetic agent. Cancer 2010, 116:4670-4676.
16. Hesson L., Bieche I., Krex D., Criniere E., Hoang-Xuan K., Maher E.R., Latif F. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Oncogene 2004, 23:2408-2419.
17. Luo X.J., Li L.L., Deng Q.P., Yu X.F., Yang L.F., Luo F.J., Xiao L.B., Chen X.Y., Ye M., Liu J.K., Cao Y. Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells. Eur. J. Cancer 2011, 47:316-325.
18. Xiong H., Du W., Zhang Y.J., Hong J., Su W.Y., Tang J.T., Wang Y.C., Lu R., Fang J.Y. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells. Mol. Carcinog. 2012, 51:174-184.
19. Gupta S.C., Phromnoi K., Aggarwal B.B. Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1. Biochem. Pharmacol. 2013, 85:898-912.
20. Chuang Y.T., Fang L.W., Lin-Feng M.H., Chen R.H., Lai M.Z. The tumor suppressor death-associated protein kinase targets to TCR-stimulated NF-kappa B activation. J. Immunol. 2008, 180:3238-3249.
21. Oeckinghaus A., Hayden M.S., Ghosh S. Crosstalk in NF-kappaB signaling pathways. Nat. Immunol. 2011, 12:695-708.
22. Bialik S., Kimchi A. The death-associated protein kinases: structure, function, and beyond. Annu. Rev. Biochem. 2006, 75:189-210.
23. Lee J.H., Rho S.B., Chun T. Programmed cell death 6 (PDCD6) protein interacts with death-associated protein kinase 1 (DAPk1): additive effect on apoptosis via caspase-3 dependent pathway. Biotechnol. Lett. 2005, 27:1011-1015.
24. Sato N., Kawai T., Sugiyama K., Muromoto R., Imoto S., Sekine Y., Ishida M., Akira S., Matsuda T. Physical and functional interactions between STAT3 and ZIP kinase. Int. Immunol. 2005, 17:1543-1552.
25. Shani G., Marash L., Gozuacik D., Bialik S., Teitelbaum L., Shohat G., Kimchi A. Death-associated protein kinase phosphorylates ZIP kinase, forming a unique kinase hierarchy to activate its cell death functions. Mol. Cell Biol. 2004, 24:8611-8626.